Groups representing most of the American medical establishment have become involved in two major patent cases that turn on the question of just what kinds of technology should be eligible for patent protection.
One of those cases, Prometheus Laboratories v. Mayo Collaborative Services , 04-cv-1200, is now headed to the Federal Circuit U.S. Court of Appeals; oral arguments are scheduled for Aug. 5. Amicus curiae briefs filed on both sides show clearly the divide between the patent bar and medical professionals on this issue.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
